Viessmann has acquired a significant minority stake in schülke, a leader in infection prevention and control, enhancing its portfolio in the healthcare sector focused on sustainability.
Information on the Target
The Viessmann Generations Group, commonly known as Viessmann, is a prominent family-owned company with over a century-long heritage, having been established in 1917. Recently, Viessmann has acquired a significant minority stake in schülke, a leader in sustainability within the infection prevention and treatment sector, particularly for healthcare and life sciences. This investment places Viessmann among key shareholders, including ATHOS, a Munich-based family office, and Bitburger Holding.
schülke has nearly 135 years of experience in the industry, positioning itself as an innovative leader and critical partner to healthcare settings. The company focuses on comprehensive solutions for infection prevention and treatment, gaining a robust reputation with healthcare facilities like hospitals, pharmacies, and the life sciences sector across Central and Eastern Europe, Australia, and Brazil.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
Germany's healthcare industry is characterized by its advanced infrastructure, proactive regulation, and a commitment to quality care, driven partly by innovation in medical technologies. The country boasts one of the highest healthcare ex
Similar Deals
Wellhub → Urban Sports Club
2025
Teleflex Incorporated → Vascular Intervention division of BIOTRONIK
2025
Bristol Myers Squibb → Evotec SE
2025
Viessmann Generations Group
invested in
schülke
in 2024
in a Strategic Partnership deal